Navigating an executive leadership change? Use our eBook to facilitate a smooth transition. Download Now

Westicke Partners

Close

Life Sciences and Healthcare SPACs

Many companies are wondering if they should consider a SPAC transaction as an alternative to a traditional IPO. In this webinar, panelists discuss considerations around SPAC transactions.

Life Sciences - Healthcare SPACs

Life Sciences and Healthcare SPACs: An Alternate Pathway to Going Public

September 2020 – Special purpose acquisition company (SPAC) IPOs have raised a record amount of capital this year, and an increasing number of companies are considering SPAC transactions as an alternative to a traditional IPO. In this webinar, experts discussed considerations around SPAC transactions vs. traditional IPOs.

Topics include:

  • The SPAC business combination process
  • SPAC sponsors’ increasing focus on life sciences and healthcare
  • Considerations associated with going public through a SPAC business combination compared to a traditional IPO

Click to view the webinar

 

Clinical trial data disclosure can be tricky.

Download our checklist of 10 disclosure guidelines to minimize risk and maximize the impact of good news.

Download Now

Our Locations